Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education

D. Gurwitz, J. E. Lunshof, G. Dedoussis, C. S. Flordellis, U. Fuhr, J. Kirchheiner, J. Licinio, A. Llerena, V. G. Manolopoulos, L. J. Sheffield, G. Siest, F. Torricelli, V. Vasiliou, S. Wong

Research output: Contribution to journalArticlepeer-review

95 Citations (Scopus)

Abstract

Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decades. Efforts are evident to clarify the potential bioethical, societal, and legal implications of key pharmacogenomics-based technologies projected to be soon introduced into the core practice of medicine. In sharp contrast, a lack of sufficient attention to educational aspects of pharmacogenomics, both for professionals and for society at large, is evident. In order to contribute to this discussion, a 'Pharmacogenomics Education Forum' was held on October 2, 2004 during the 3rd Annual Meeting of the International Society of Pharmacogenomics (ISP) at Santorini, Greece. The participants, members of the ISP Pharmacogenomics Education Forum, after deliberate discussions, proposed a document of 'Background Statement' and 'Recommendations and Call for Action' addressed to Deans of Education at Medical, Pharmaceutical, and Health Schools globally. This document has been considered by the education committee of the International Society of Pharmacogenomics and the result is presented here. We hope that this call would be listened to, and soon followed by beneficial action, ultimately leading to enhanced implementation of personalized medicine into core medical education and practice.

Original languageEnglish
Pages (from-to)221-225
Number of pages5
JournalPharmacogenomics Journal
Volume5
Issue number4
DOIs
Publication statusPublished or Issued - 2005

Keywords

  • Adverse drug reactions (ADRs)
  • Continuing medical education
  • Cytochrome P450 enzymes
  • Education
  • International Society of Pharmacogenetics (ISP)
  • Personalized medicine
  • Pharmacogenetics
  • Thiopurine methyltransferase (TPMT)

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this